Skip to content
OpenCapital
Get started

ADMA Biologics ADMA ADMA Bio Manufacturing — Total Assets

Other segment segments

Plasma Collection Centers
$25.26M-8.6%

Similar metrics at other companies

Chemours logo
CCAdvanced Performance Materials — Total Assets
$1.67B-4.8%
Huntsman logo
HUNAdvanced Materials — Total Assets
$1.12B—
H.B. Fuller logo
FULBuilding Adhesives Solutions — Total Assets
$1.19B-4.1%
Thermo Fisher Scientific logo
TMOLaboratory Products and Biopharma Services — Segment assets
$6.92B+7.0%
Abbott logo
ABTMedical Devices — Total Assets
$10.98B+9.5%
Abbott logo
ABTDiagnostic Products — Total Assets
$9.63B+22.8%

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.01B-54.5%
Enterprise value$2.08B-52.5%
P/E12.2×-9.2×
P/S4×-5.7×

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's adma bio manufacturing — total assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's ADMA bio manufacturing — total assets?
ADMA Biologics (ADMA) reported ADMA bio manufacturing — total assets of $429.29M in Q1 2026.
How has ADMA Biologics's ADMA bio manufacturing — total assets changed year-over-year?
ADMA Biologics's ADMA bio manufacturing — total assets increased by 30.1% year-over-year, from $330.09M to $429.29M.
What is the long-term trend for ADMA Biologics's ADMA bio manufacturing — total assets?
Over 4 years (2021 to 2025), ADMA Biologics's ADMA bio manufacturing — total assets has grown at a 20.9% compound annual growth rate (CAGR), from $723.75M to $1.54B.
What does ADMA bio manufacturing — total assets mean?
This metric represents the total economic resources controlled by the BioManufacturing segment, including inventory, manufacturing equipment, and specialized facilities. It provides a snapshot of the asset base dedicated to the production and distribution of plasma-derived biologics. Analyzing this figure helps assess the segment's operational scale and the efficiency with which it utilizes its asset base to generate revenue.